MJA
MJA

Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners

Mark R Nelson
Med J Aust 2004; 180 (3): . || doi: 10.5694/j.1326-5377.2004.tb05841.x
Published online: 2 February 2004

Mark R Nelson

Online responses are no longer available. Please refer to our instructions for authors page for more information.